Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya. PLoS ONE 2017;12(9):e0183788 doi: 10.1371/journal.pone.0183788
Scientific Publications
- PMID: 28880880
- Title: Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi Kenya
- Abstract: 1.5 million Kenyans are living with HIV/AIDS as per 2015 estimates. Though there is a notable decline in new HIV infections, continued effort is still needed to develop an efficacious, accessible and affordable HIV vaccine. HIV vaccine clinical trials bear risks, hence a need to understand volunteer motivators for enrolment, retention and follow-up. Understanding the factors that motivate volunteers to participate in a clinical trial can help to strategize, refine targeting and thus increase enrolment of volunteers in future HIV vaccine clinical trials. The health belief model classifies motivators into social benefits such as 'advancing research' and collaboration with science, and personal benefits such as health benefits and financial interests.
- Date: 1970-08-21
- Year: 2017
- Journal: PLoS ONE
- PMID Author: Nyaoke BA, Mutua GN, Sajabi R, Nyasani D, Mureithi MW, Anzala OA
- PMC Link #: PMC5589082
- IAVI Topics: Capacity Building and Research Preparedness
Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi Kenya
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
